Italia markets open in 42 minutes

Aytu BioPharma, Inc. (0A8M.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5250+0,0050 (+0,96%)
Alla chiusura: 04:21PM BST
Schermo intero
Chiusura precedente0,5200
Aperto0,5250
Denaro0,0000 x N/D
Lettera0,0000 x N/D
Min-Max giorno0,5250 - 0,5250
Intervallo di 52 settimane0,5250 - 0,5250
Volume200
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)-0,11
Rapporto PE (ttm)N/D
EPS (ttm)-4,2400
Prossima data utili26 set 2022 - 30 set 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    SHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the Firm

    SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of the officers and board of directors of Odonate Therapeutics, Inc., Aytu Biopharma, Inc., Eargo, Inc., and Corcept Therapeutics, Inc. If you are a current owner of shares of any of these stocks, contact leo@moka.law or call (619) 708-3993. Odonate Therapeutics, Inc. (NASDAQ: ODT) Accused of Misleading Investors On August 4, 2021, Judge Marilyn Huff. of the United States District Court f